Your Policies Are Always One Regulatory Change Behind

Subscribe Now

On April 22, 2026, the Department of Justice issued a final order rescheduling state-licensed medical marijuana and FDA-approved marijuana products from Schedule I to Schedule III of the Controlled Substances Act. For most employers, this registered as regulatory news, significant, but something to address later.

What it actually did was expose a gap that was already there.

What the Rescheduling Changed

Schedule I was the legal foundation on which courts consistently dismissed ADA accommodation claims tied to medical marijuana. The logic was straightforward: Schedule I means no accepted medical use, which meant no recognized federal medical purpose, which meant ADA protections for prescribed medications didn’t apply. Courts had a reliable basis for rejecting those claims. That basis is now materially weaker.

State medical marijuana certifications are federally recognized as a legitimate medical category. Employees who use state-licensed medical marijuana can make a more credible case that their use warrants the same reasonable accommodation analysis the ADA requires for other prescribed medications. The interactive accommodation process your organization has likely handled with relative predictability is operating in a different legal environment.

What didn’t change matters just as much. Recreational marijuana and synthetic THC remain Schedule I. The order doesn’t require you to permit impairment at work. For DOT-regulated employers in transportation, aviation, and rail, existing testing requirements under 49 CFR Part 40 remain in effect. Agency guidance on accommodation requests in regulated roles is still pending, current protocols apply until it arrives.

Zero-tolerance policies that don’t distinguish between impairment at work and off-duty medical use are under more scrutiny than before. That distinction was easier to defend when there was no recognized federal medical purpose for marijuana. It’s less straightforward now.

The Bigger Issue This Surfaces

Here’s what’s worth examining beyond this specific change.

Most organizations find out their policies are outdated when a claim surfaces. Not when the regulatory ground shifts, but after it has shifted, when someone tests whether the existing policy holds up. The drug and alcohol policy that was legally sound two years ago is now operating in a different ADA landscape. Most organizations haven’t updated it yet. They won’t know whether their zero-tolerance language creates exposure until the exposure arrives.

This plays out across policy infrastructure more broadly. WARN Act thresholds changed in several states on January 1, 2026, many organizations haven’t checked their processes against the new requirements. Pay transparency obligations are expanding faster than most multi-state employers have tracked. The marijuana rescheduling isn’t exceptional. It’s the latest instance of a consistent pattern: regulatory environments evolve continuously, but most policy infrastructure is built for stability and only updates in response to pressure.

The organizations that manage this well don’t just update faster when changes happen. They have a process for anticipating when policies need review, a regular cadence, not a reaction. The gap gets closed before it opens, not after a complaint makes it visible.

What to Do Right Now

The April rescheduling is recent enough that a review done now is still proactive. That window matters. Organizations that review their drug and alcohol policies before accommodation requests increase are in a meaningfully better position than those that wait.

The review doesn’t need to be complex. Here’s where to start:

Review your drug and alcohol policy. Does your language distinguish medical use from recreational use? Is your accommodation process clearly defined and consistently applied?
Assess your zero-tolerance policy. If it doesn’t distinguish between impairment at work and lawful off-duty medical use, it may be worth revisiting before a claim surfaces.
Train your managers. Employees will ask questions. Managers need to know how to respond consistently and where to direct accommodation requests.
If you’re DOT-regulated, monitor closely. Agency-specific guidance is expected. Stay current and be prepared to move when it arrives.

These are answerable questions. The more important one is whether your organization has a routine process for asking them, not just when a headline prompts you to.

The organizations that take a proactive look now will be better positioned than those that wait for an issue to arise. If you’d like to review your current drug and alcohol policies in light of the April 2026 rescheduling, or talk through how this change affects your specific workforce, reach out to our team at convergehrsolutions.com.

Talk to the Converge Team

Sources: